SCHEMBL6513091

SCHEMBL6513091

COC(=O)[C@H](CC(C)C)Nc1nc(NCC2CCCO2)nc(Oc2ccc(OC)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 2/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 2/20 0.43
NPR3 P17342 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 3/20 0.43
GAA P10253 2/20 0.43
HSD17B10 Q99714 2/20 0.43
GLA P06280 1/20 0.43
RECQL P46063 1/20 0.42
RAB9A P51151 1/20 0.42
KCNH3 Q9ULD8 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6531904 1.00 HPGD (0.46) HPGDSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL6532622 0.78 KCNH3 (0.51) HPGDSMN1; SMN2LMNAMAPTCYP2C9
SCHEMBL6532631 0.78 KCNH3 (0.51) HPGDSMN1; SMN2LMNAMAPTCYP2C9
SCHEMBL6530303 0.78 VNN1 (0.44) L3MBTL1LMNAMAPTCYP2C9NPR3
SCHEMBL6529952 0.78 NPR3 (0.42) SMN1; SMN2MAPTCYP2C9NPR3CYP2C19
SCHEMBL6529959 0.78 NPR3 (0.42) SMN1; SMN2MAPTCYP2C9NPR3CYP2C19
SCHEMBL6529224 0.76 NPR3 (0.56) SMN1; SMN2MAPTCYP2C9NPR3CYP2C19
SCHEMBL6528199 0.74 ANPEP (0.43) MAPTCYP2C9NPR3CYP2C19KCNH3
SCHEMBL6528195 0.74 ANPEP (0.43) MAPTCYP2C9NPR3CYP2C19KCNH3
SCHEMBL6529615 0.70 TAS1R3 (0.39) SMN1; SMN2MAPTCYP2C9NPR3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed